Rhenman & Partners Asset Management Ab Top Holdings and 13F Report (2024)

About Rhenman & Partners Asset Management Ab

Investment Activity

Rhenman & Partners Asset Management Ab has $1.23 billion in total holdings as of September 30, 2024.
Rhenman & Partners Asset Management Ab owns shares of 95 different stocks, but just 44 companies or ETFs make up 80% of its holdings.
Approximately 20.07% of the portfolio was purchased this quarter.
About 11.48% of the portfolio was sold this quarter.
This quarter, Rhenman & Partners Asset Management Ab has purchased 93 new stocks and bought additional shares in 39 stocks.
Rhenman & Partners Asset Management Ab sold shares of 39 stocks and completely divested from 6 stocks this quarter.

Largest Holdings

Boston Scientific: $49,442,000
UnitedHealth Group: $42,506,236
Eli Lilly and Company: $42,082,150
Regeneron Pharmaceuticals: $40,998,360
Tenet Healthcare: $36,796,680

Largest New Holdings this Quarter

Novo Nordisk A/S: $11,907,000 Holding
CVS Health: $11,569,920 Holding
Humana: $9,818,940 Holding
BioNTech: $6,057,270 Holding
Geron: $4,540,000 Holding

Largest Purchases this Quarter

Inspire Medical Systems: 105,000 shares (about $22.16M)
Exact Sciences: 320,000 shares (about $21.80M)
Medtronic: 160,000 shares (about $14.40M)
Novo Nordisk A/S: 100,000 shares (about $11.91M)
CVS Health: 184,000 shares (about $11.57M)

Largest Sales this Quarter

UnitedHealth Group: 32,600 shares (about $19.06M)
Elevance Health: 35,300 shares (about $18.36M)
Oscar Health: 535,464 shares (about $11.36M)
The Cigna Group: 32,486 shares (about $11.25M)
Alnylam Pharmaceuticals: 35,150 shares (about $9.67M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
BSX Boston Scientific	$49,442,000	$419,000 ▼	-0.8%	590,000	4.0%	Medical
UNH UnitedHealth Group	$42,506,236	$19,060,568 ▼	-31.0%	72,700	3.4%	Medical
LLY Eli Lilly and Company	$42,082,150	$442,970 ▲	1.1%	47,500	3.4%	Medical
REGN Regeneron Pharmaceuticals	$40,998,360	$7,358,680 ▲	21.9%	39,000	3.3%	Medical
THC Tenet Healthcare	$36,796,680	$1,263,120 ▼	-3.3%	221,400	3.0%	Medical
PRCT PROCEPT BioRobotics	$35,653,400	$400,600 ▲	1.1%	445,000	2.9%	Medical
ABBV AbbVie	$34,953,960	$2,369,760 ▼	-6.3%	177,000	2.8%	Medical
MDT Medtronic	$33,131,040	$14,404,800 ▲	76.9%	368,000	2.7%	Medical
EXAS Exact Sciences	$31,675,800	$21,798,400 ▲	220.7%	465,000	2.6%	Medical
HCA HCA Healthcare	$30,981,752	$2,345,507 ▼	-7.0%	76,229	2.5%	Medical
ISRG Intuitive Surgical	$30,950,010	$1,228,175 ▲	4.1%	63,000	2.5%	Medical
GILD Gilead Sciences	$30,727,360	$10,731,520 ▲	53.7%	366,500	2.5%	Medical
NTRA Natera	$29,325,450	$9,394,300 ▲	47.1%	231,000	2.4%	Medical
OSCR Oscar Health	$29,082,028	$11,357,191 ▼	-28.1%	1,371,147	2.4%	Finance
MRK Merck & Co., Inc.	$27,367,960	$7,494,960 ▲	37.7%	241,000	2.2%	Medical
BDX Becton, Dickinson and Company	$27,123,750	$120,550 ▼	-0.4%	112,500	2.2%	Medical
ELV Elevance Health	$26,260,000	$18,356,000 ▼	-41.1%	50,500	2.1%	Medical
INSP Inspire Medical Systems	$25,748,100	$22,160,250 ▲	617.6%	122,000	2.1%	Medical
BMRN BioMarin Pharmaceutical	$25,620,705	$7,942,770 ▲	44.9%	364,500	2.1%	Medical
COOPER COS INC	$25,157,520	$9,047,880 ▼	-26.5%	228,000	2.0%	COM
ALHC Alignment Healthcare	$23,372,431	$3,970,515 ▲	20.5%	1,977,363	1.9%	Medical
DHR Danaher	$23,159,622	$9,675,652 ▲	71.8%	83,302	1.9%	Multi-Sector Conglomerates
VRTX Vertex Pharmaceuticals	$22,207,570	$2,906,750 ▼	-11.6%	47,750	1.8%	Medical
RPRX Royalty Pharma	$17,355,915	$1,946,437 ▲	12.6%	613,500	1.4%	Finance
TMO Thermo Fisher Scientific	$15,526,107	$680,427 ▲	4.6%	25,100	1.3%	Medical
ABT Abbott Laboratories	$15,391,350	$1,140,100 ▼	-6.9%	135,000	1.2%	Medical
ITCI Intra-Cellular Therapies	$15,036,435	$4,646,295 ▲	44.7%	205,500	1.2%	Medical
MCK McKesson	$14,890,447	$57,847 ▲	0.4%	30,117	1.2%	Medical
GKOS Glaukos	$14,461,080	$7,947,080 ▲	122.0%	111,000	1.2%	Medical
CI The Cigna Group	$14,441,351	$11,254,450 ▼	-43.8%	41,685	1.2%	Medical
ALGN Align Technology	$13,987,600	$381,480 ▼	-2.7%	55,000	1.1%	Medical
ALNY Alnylam Pharmaceuticals	$13,847,761	$9,667,305 ▼	-41.1%	50,350	1.1%	Medical
DVAX Dynavax Technologies	$13,256,600	$471,902 ▼	-3.4%	1,190,000	1.1%	Medical
BIIB Biogen	$13,006,664	$3,430,968 ▼	-20.9%	67,100	1.1%	Medical
NVO Novo Nordisk A/S	$11,907,000	$11,907,000 ▲	New Holding	100,000	1.0%	Medical
CVS CVS Health	$11,569,920	$11,569,920 ▲	New Holding	184,000	0.9%	Retail/Wholesale
IQV IQVIA	$11,374,560	$4,028,490 ▲	54.8%	48,000	0.9%	Medical
AXSM Axsome Therapeutics	$11,018,062	$449,350 ▼	-3.9%	122,600	0.9%	Medical
APLS Apellis Pharmaceuticals	$10,598,700	$9,001,108 ▲	563.4%	367,500	0.9%	Medical
JAZZ Jazz Pharmaceuticals	$10,361,130	$2,339,610 ▼	-18.4%	93,000	0.8%	Medical
MOH Molina Healthcare	$10,198,976	$7,787,056 ▲	322.9%	29,600	0.8%	Medical
COR Cencora	$10,162,362	$1,429,258 ▼	-12.3%	45,150	0.8%	Medical
IOVA Iovance Biotherapeutics	$9,882,975	$1,244,175 ▲	14.4%	1,052,500	0.8%	Medical
HUM Humana	$9,818,940	$9,818,940 ▲	New Holding	31,000	0.8%	Medical
CYTK Cytokinetics	$9,530,400	$898,392 ▼	-8.6%	180,500	0.8%	Medical
INSM Insmed	$9,454,449	$2,190,000 ▲	30.1%	129,513	0.8%	Medical
PODD Insulet	$9,310,000	$1,512,875 ▼	-14.0%	40,000	0.8%	Medical
NUVL Nuvalent	$9,207,000	$741,675 ▲	8.8%	90,000	0.7%	Medical
CNC Centene	$8,806,405	$6,135,320 ▼	-41.1%	116,982	0.7%	Medical
SYK Stryker	$8,308,980	$1,806,300 ▲	27.8%	23,000	0.7%	Medical
NBIX Neurocrine Biosciences	$8,267,035	$438,412 ▼	-5.0%	71,750	0.7%	Medical
IONS Ionis Pharmaceuticals	$7,811,700	$2,603,900 ▲	50.0%	195,000	0.6%	Medical
EVH Evolent Health	$7,494,200	$6,080,200 ▲	430.0%	265,000	0.6%	Computer and Technology
CRL Charles River Laboratories International	$7,386,375	$689,395 ▲	10.3%	37,500	0.6%	Medical
TMDX TransMedics Group	$7,107,390	$4,987,890 ▲	235.3%	45,270	0.6%	Medical
IMVT Immunovant	$6,927,930	$3,207,375 ▲	86.2%	243,000	0.6%	Medical
BBIO BridgeBio Pharma	$6,823,280	$2,125,910 ▲	45.3%	268,000	0.6%	Medical
NRIX Nurix Therapeutics	$6,741,000	$2,822,389 ▲	72.0%	300,000	0.5%	Medical
ACHC Acadia Healthcare	$6,705,608	$4,180,368 ▲	165.5%	105,750	0.5%	Medical
VKTX Viking Therapeutics	$6,489,275	$791,375 ▼	-10.9%	102,500	0.5%	Medical
BNTX BioNTech	$6,057,270	$6,057,270 ▲	New Holding	51,000	0.5%	Medical
EHC Encompass Health	$5,895,040	$96,640 ▲	1.7%	61,000	0.5%	Medical
DXCM DexCom	$5,832,480	$2,011,200 ▼	-25.6%	87,000	0.5%	Medical
SNDX Syndax Pharmaceuticals	$4,995,375	$596,750 ▲	13.6%	259,500	0.4%	Medical
EPIX ESSA Pharma	$4,876,173	$8,514 ▼	-0.2%	804,649	0.4%	Medical
JANX Janux Therapeutics	$4,854,059		0.0%	106,847	0.4%	Medical
GERN Geron	$4,540,000	$4,540,000 ▲	New Holding	1,000,000	0.4%	Medical
DIANTHUS THERAPEUTICS INC	$4,107,000	$4,107,000 ▲	New Holding	150,000	0.3%	COM
XNCR Xencor	$4,097,413	$301,650 ▼	-6.9%	203,750	0.3%	Medical
MIRM Mirum Pharmaceuticals	$4,095,000	$1,140,750 ▼	-21.8%	105,000	0.3%	Medical
IDYA IDEAYA Biosciences	$4,039,200	$2,344,320 ▲	138.3%	127,500	0.3%	Medical
TGTX TG Therapeutics	$4,011,385	$982,380 ▼	-19.7%	171,500	0.3%	Medical
MRUS Merus	$3,971,820	$549,560 ▼	-12.2%	79,500	0.3%	Medical
ALKS Alkermes	$3,722,670	$475,830 ▼	-11.3%	133,000	0.3%	Medical
ANNX Annexon	$3,315,200	$2,012,800 ▼	-37.8%	560,000	0.3%	Medical
ESPR Esperion Therapeutics	$3,258,750		0.0%	1,975,000	0.3%	Medical
RLAY Relay Therapeutics	$3,256,800	$1,628,400 ▲	100.0%	460,000	0.3%	Medical
KURA Kura Oncology	$3,253,918		0.0%	166,526	0.3%	Medical
MDGL Madrigal Pharmaceuticals	$3,246,966	$2,376,864 ▼	-42.3%	15,300	0.3%	Medical
ARVN Arvinas	$3,214,215	$2,450,685 ▼	-43.3%	130,500	0.3%	Medical
KRYS Krystal Biotech	$3,094,510	$364,060 ▼	-10.5%	17,000	0.3%	Medical
IGMS IGM Biosciences	$3,067,492	$157,808 ▼	-4.9%	185,459	0.2%	Medical
BRKR Bruker	$3,060,394	$2,646,034 ▲	638.6%	44,315	0.2%	Computer and Technology
ACLX Arcellx	$2,672,320	$2,672,320 ▲	New Holding	32,000	0.2%	Medical
MEDP Medpace	$2,503,500	$1,669,000 ▲	200.0%	7,500	0.2%	Medical
UHS Universal Health Services	$1,832,080	$1,832,080 ▲	New Holding	8,000	0.1%	Medical
IMCR Immunocore	$1,814,194		0.0%	58,278	0.1%	Medical
PRVA Privia Health Group	$1,733,392	$342,548 ▼	-16.5%	95,189	0.1%	Medical
TECH Bio-Techne	$1,598,600		0.0%	20,000	0.1%	Medical
RGEN Repligen	$1,488,200		0.0%	10,000	0.1%	Medical
XENE Xenon Pharmaceuticals	$1,377,950		0.0%	35,000	0.1%	Medical
PLRX Pliant Therapeutics	$1,348,003		0.0%	120,250	0.1%	Medical
AVTR Avantor	$1,138,280	$413,920 ▼	-26.7%	44,000	0.1%	Medical
AMGN Amgen	$966,630	$402,763 ▼	-29.4%	3,000	0.1%	Medical
INMB INmune Bio	$960,951		0.0%	178,284	0.1%	Medical
EW Edwards Lifesciences	$0	$9,006,075 ▼	-100.0%	0	0.0%	Medical
PEN Penumbra	$0	$4,139,310 ▼	-100.0%	0	0.0%	Medical
STAA STAAR Surgical	$0	$3,094,650 ▼	-100.0%	0	0.0%	Medical
RVNC Revance Therapeutics	$0	$1,803,387 ▼	-100.0%	0	0.0%	Medical
NARI Inari Medical	$0	$963,000 ▼	-100.0%	0	0.0%	Medical

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rhenman & Partners Asset Management Ab Top Holdings and 13F Report (2024)

About Rhenman & Partners Asset Management Ab

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rhenman & Partners Asset Management Ab Top Holdings and 13F Report (2024)

About Rhenman & Partners Asset Management Ab

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofRhenman & Partners Asset Management Ab

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools